Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems

被引:60
作者
Pardridge, WM [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
来源
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY | 1999年 / 2卷 / 02期
关键词
D O I
10.1016/S1461-5347(98)00117-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Brain drug development is limited by the blood-brain barrier (BBB), which restricts the passage into the brain of >95% of all drug candidates intended for the CNS. The growth of future CNS drug development can be accelerated by fostering parallel growth in both CNS drug discovery and CNS drug delivery One approach to solving the BBB problem is to target endogenous BBB transport systems, and to develop CNS drug delivery strategies that take advantage of these natural portals of entry into the brain.
引用
收藏
页码:49 / 59
页数:11
相关论文
共 50 条
[1]   PHARMACOLOGICAL EFFECTS INVIVO IN BRAIN BY VECTOR-MEDIATED PEPTIDE DRUG DELIVERY [J].
BICKEL, U ;
YOSHIKAWA, T ;
LANDAW, EM ;
FAULL, KF ;
PARDRIDGE, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2618-2622
[2]   IN-VIVO DEMONSTRATION OF SUBCELLULAR-LOCALIZATION OF ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODY-COLLOIDAL GOLD CONJUGATE IN BRAIN CAPILLARY ENDOTHELIUM [J].
BICKEL, U ;
KANG, YS ;
YOSHIKAWA, T ;
PARDRIDGE, WM .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (11) :1493-1497
[3]  
BLASBERG RG, 1975, J PHARMACOL EXP THER, V195, P73
[4]   Radiolabeling of epidermal growth factor with Tc-99m and in vivo localization following intracerebral injection into normal and glioma-bearing rats [J].
Capala, J ;
Barth, RF ;
Bailey, MQ ;
Fenstermaker, RA ;
Marek, MJ ;
Rhodes, BA .
BIOCONJUGATE CHEMISTRY, 1997, 8 (03) :289-295
[5]  
DEGUCHI Y, IN PRESS BIOCONJ CHE
[6]   THE VASCULARIZATION OF THE HUMAN CEREBELLAR CORTEX [J].
DUVERNOY, H ;
DELON, S ;
VANNSON, JL .
BRAIN RESEARCH BULLETIN, 1983, 11 (04) :419-480
[7]  
FENSTERMAKER RA, 1995, LEUKEMIA, V9, pS106
[8]   ANTITRANSFERRIN RECEPTOR ANTIBODY AND ANTIBODY-DRUG CONJUGATES CROSS THE BLOOD-BRAIN-BARRIER [J].
FRIDEN, PM ;
WALUS, LR ;
MUSSO, GF ;
TAYLOR, MA ;
MALFROY, B ;
STARZYK, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4771-4775
[9]  
GREEN NM, 1990, METHOD ENZYMOL, V184, P51
[10]   PHARMACOKINETICS OF CHLORAMBUCIL-TERTIARY BUTYL ESTER, A LIPOPHILIC CHLORAMBUCIL DERIVATIVE THAT ACHIEVES AND MAINTAINS HIGH-CONCENTRATIONS IN BRAIN [J].
GREIG, NH ;
DALY, EM ;
SWEENEY, DJ ;
RAPOPORT, SI .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) :320-325